Disease · fungal

Phyllosticta leaf spot of cranberry

Phyllosticta vaccinii

Description

Phyllosticta leaf spot is a fungal disease affecting cranberry crops, caused by the pathogen Phyllosticta vaccinii. This disease primarily affects the foliage, leading to necrosis and premature defoliation. As an ascomycete fungus, it relies on host tissue for nutrients and reproduction, significantly impacting the plant's metabolic health.

The host range of this fungus is primarily restricted to members of the Ericaceae family, particularly cranberries (Vaccinium macrocarpon). In commercial agriculture, the disease is considered economically significant because it reduces the leaf area available for photosynthesis, thereby limiting the accumulation of carbohydrates necessary for fruit production.

The infection manifests as characteristic lesions on the leaves. These spots often appear circular or irregular with a light-colored center surrounded by a darker purple or brown necrotic border. Under magnifying conditions, tiny, black, flask-shaped reproductive structures known as pycnidia can be observed scattered across the center of the necrotic tissue.

The development and spread of Phyllosticta vaccinii are heavily influenced by environmental moisture. Periods of prolonged leaf wetness, high humidity, and moderate temperatures provide optimal conditions for the infection cycle. The fungus overwintering on fallen leaves and stem debris serves as the primary inoculum for the subsequent growing season.

Management strategies for controlling leaf spot focus on reducing the pathogen load and improving crop vigor. Key measures include:

  • Implementing regular pruning to increase air circulation and reduce canopy humidity.
  • Sanitation protocols involving the removal and destruction of infected debris.
  • Applying appropriate fungicides, such as copper-based formulations, before and after bloom stages.
  • Maintaining balanced nutrient levels to support plant resistance to fungal pathogens.

Marketplace

Products · 0

Community

Discussion

No discussions yet — be the first.